skip to main content
Show Results with:

3 results  for Everything in this catalogue

Refined by: subject: Infection--Périodiques remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

Perez-Molina, José A et al.

The Lancet infectious diseases. Volume 15:Issue 7 (2015, July); pp 775-784 -- Elsevier Science

Online access

2
Material Type:
Article
Add to My workspace

Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

Perez-Molina, José A et al.

The Lancet infectious diseases. Volume 15:Issue 7 (2015, July); pp 775-784 -- Elsevier Science

Online access

3
Material Type:
Article
Add to My workspace

Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

Perez-Molina, José A et al.

The Lancet infectious diseases. Volume 15:Issue 7 (2015, July); pp 775-784 -- Elsevier Science

Online access

3 results  for Everything in this catalogue

Refine Search Results

Refine my results

Author/Contributor 

  1. Navarro, José  (2)
  2. Navarro, Jordi  (1)
  3. GESIDA 7011 Study Group  (1)
  4. Refine further open sub menu

Try a new search

Ignore my search and look for everything

by this Author/Contributor:

  1. Riera, Melcior
  2. Rivero, Antonio
  3. Mariño, Ana
  4. Rubio, Rafael
  5. Sanz-Moreno, José

Searching Remote Databases, Please Wait